2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinomaskin squamous cell carcinomaActive, not recruitingPhase 32026-03-27NCT03969004
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityEGFR Inhibitor-associated RashRecruitingPhase 1 / Phase 22026-02-11NCT06830863